Golden State Equity Partners’s Mereo BioPharma MREO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $53.9K | Hold |
19,900
| – | – | 0.01% | 432 |
|
|
2025
Q1 | $44.8K | Sell |
19,900
-2,700
| -12% | -$6.08K | 0.01% | 429 |
|
|
2024
Q4 | $79.1K | Buy |
22,600
+16,100
| +248% | +$56.4K | 0.02% | 429 |
|
|
2024
Q3 | $26.7K | Sell |
6,500
-18,300
| -74% | -$75.2K | 0.01% | 476 |
|
|
2024
Q2 | $89.3K | Buy |
+24,800
| New | +$89.3K | 0.02% | 397 |
|
|
2023
Q4 | $46.9K | Buy |
20,300
+5,900
| +41% | +$13.6K | 0.01% | 357 |
|
|
2023
Q3 | $18.6K | Hold |
14,400
| – | – | 0.01% | 335 |
|
|
2023
Q2 | $19K | Hold |
14,400
| – | – | 0.01% | 369 |
|
|
2023
Q1 | $10.2K | Buy |
+14,400
| New | +$10.2K | 0.01% | 214 |
|
|
2022
Q1 | $23K | Hold |
20,300
| – | – | 0.01% | 192 |
|
|
2021
Q4 | $32K | Buy |
+20,300
| New | +$32K | 0.02% | 173 |
|